372 related articles for article (PubMed ID: 32166845)
21. Actionable pharmacogenetic variants in Hong Kong Chinese exome sequencing data and projected prescription impact in the Hong Kong population.
Yu MHC; Chan MCY; Chung CCY; Li AWT; Yip CYW; Mak CCY; Chau JFT; Lee M; Fung JLF; Tsang MHY; Chan JCK; Wong WHS; Yang J; Chui WCM; Chung PHY; Yang W; Lee SL; Chan GCF; Tam PKH; Lau YL; Tang CSM; Yeung KS; Chung BHY
PLoS Genet; 2021 Feb; 17(2):e1009323. PubMed ID: 33600428
[TBL] [Abstract][Full Text] [Related]
22. Drug Use in Denmark for Drugs Having Pharmacogenomics (PGx) Based Dosing Guidelines from CPIC or DPWG for CYP2D6 and CYP2C19 Drug-Gene Pairs: Perspectives for Introducing PGx Test to Polypharmacy Patients.
Westergaard N; Søgaard Nielsen R; Jørgensen S; Vermehren C
J Pers Med; 2020 Jan; 10(1):. PubMed ID: 31963319
[TBL] [Abstract][Full Text] [Related]
23. Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting.
Cohn I; Manshaei R; Liston E; Okello JBA; Khan R; Curtis MR; Krupski AJ; Jobling RK; Kalbfleisch K; Paton TA; Reuter MS; Hayeems RZ; Verstegen RHJ; Goldman A; Kim RH; Ito S
JAMA Netw Open; 2021 May; 4(5):e2110446. PubMed ID: 34037732
[TBL] [Abstract][Full Text] [Related]
24. Use of drugs with pharmacogenomics (PGx)-based dosing guidelines in a Danish cohort of persons with chronic kidney disease, both on dialysis and not on dialysis: Perspectives for prescribing optimization.
Westergaard N; Baltzer Houlind M; Christrup LL; Juul-Larsen HG; Strandhave C; Olesen AE
Basic Clin Pharmacol Toxicol; 2024 Apr; 134(4):531-542. PubMed ID: 38308569
[TBL] [Abstract][Full Text] [Related]
25. Identification of high-impact gene-drug pairs for pharmacogenetic testing in Alberta, Canada.
Fan M; Yarema MC; Box A; Hume S; Aitchison KJ; Bousman CA
Pharmacogenet Genomics; 2021 Feb; 31(2):29-39. PubMed ID: 32826605
[TBL] [Abstract][Full Text] [Related]
26. Economic Utility: Combinatorial Pharmacogenomics and Medication Cost Savings for Mental Health Care in a Primary Care Setting.
Brown LC; Lorenz RA; Li J; Dechairo BM
Clin Ther; 2017 Mar; 39(3):592-602.e1. PubMed ID: 28238356
[TBL] [Abstract][Full Text] [Related]
27. Appropriateness of psychotropic drug prescriptions in the elderly: structuring tools based on data extracted from the hospital information system to understand physician practices.
Petit-Monéger A; Jouhet V; Thiessard F; Berdaï D; Noize P; Gilleron V; Caridade G; Salmi LR; Saillour-Glénisson F
BMC Health Serv Res; 2019 Apr; 19(1):272. PubMed ID: 31039784
[TBL] [Abstract][Full Text] [Related]
28. Pharmacist-Initiated Pre-Emptive Pharmacogenetic Panel Testing with Clinical Decision Support in Primary Care: Record of PGx Results and Real-World Impact.
van der Wouden CH; Bank PCD; Özokcu K; Swen JJ; Guchelaar HJ
Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146504
[TBL] [Abstract][Full Text] [Related]
29. [Impact of therapeutic advice on prescription of psychotropics for patients with serious mental illness].
Lebas E; Clerc B; Mangavelle J; Megard R; Franck N
Encephale; 2019 Sep; 45(4):304-311. PubMed ID: 30902340
[TBL] [Abstract][Full Text] [Related]
30. Description of Pharmacogenomic Testing Among Patients Admitted to the Intensive Care Unit After Cardiovascular Surgery.
Peterson PE; Nicholson WT; Moyer AM; Arendt CJ; Smischney NJ; Seelhammer TG; Krecke CA; Haney RM; Yaw EJ; Chlan LL
J Intensive Care Med; 2021 Nov; 36(11):1281-1285. PubMed ID: 32734840
[TBL] [Abstract][Full Text] [Related]
31. ADME Gene-Related Pharmacogenomic Labeling of FDA-Approved Drugs: Comparison with Clinical Pharmacogenetics Implementation Consortium (CPIC) Evidence Levels.
Deb S; Hopefl R; Reeves AA; Cvetkovic D
Medicines (Basel); 2024 Feb; 11(3):. PubMed ID: 38535119
[TBL] [Abstract][Full Text] [Related]
32. Identifying the prevalence of clinically actionable drug-gene interactions in a health system biorepository to guide pharmacogenetics implementation services.
Pasternak AL; Ward K; Irwin M; Okerberg C; Hayes D; Fritsche L; Zoellner S; Virzi J; Choe HM; Ellingrod V
Clin Transl Sci; 2023 Feb; 16(2):292-304. PubMed ID: 36510710
[TBL] [Abstract][Full Text] [Related]
33. Projected impact of a multigene pharmacogenetic test to optimize medication prescribing in cardiovascular patients.
Dong OM; Li A; Suzuki O; Oni-Orisan A; Gonzalez R; Stouffer GA; Lee CR; Wiltshire T
Pharmacogenomics; 2018 Jun; 19(9):771-782. PubMed ID: 29793377
[TBL] [Abstract][Full Text] [Related]
34. Prescription patterns of outpatients and the potential of multiplexed pharmacogenomic testing.
Chan SL; Liew HZW; Nguyen F; Thumboo J; Chow WC; Sung C
Br J Clin Pharmacol; 2021 Mar; 87(3):886-894. PubMed ID: 32559336
[TBL] [Abstract][Full Text] [Related]
35. Drug prescriptions to outpatient children: a review of the literature.
Clavenna A; Bonati M
Eur J Clin Pharmacol; 2009 Aug; 65(8):749-55. PubMed ID: 19529926
[TBL] [Abstract][Full Text] [Related]
36. A retrospective analysis of preemptive pharmacogenomic testing in 22,918 individuals from China.
Huang Q; Liao Y; Yu T; Lei W; Liang H; Wen J; Liu Q; Chen Y; Huang K; Jing L; Huang X; Liu Y; Yu X; Su K; Liu T; Yang L; Huang M
J Clin Lab Anal; 2023 Mar; 37(5):e24855. PubMed ID: 36916827
[TBL] [Abstract][Full Text] [Related]
37. Projected Prevalence of Actionable Pharmacogenetic Variants and Level A Drugs Prescribed Among US Veterans Health Administration Pharmacy Users.
Chanfreau-Coffinier C; Hull LE; Lynch JA; DuVall SL; Damrauer SM; Cunningham FE; Voight BF; Matheny ME; Oslin DW; Icardi MS; Tuteja S
JAMA Netw Open; 2019 Jun; 2(6):e195345. PubMed ID: 31173123
[TBL] [Abstract][Full Text] [Related]
38. Prescription drug use in pregnancy and variations according to prior psychiatric history.
Ingstrup KG; Liu X; Gasse C; Debost JP; Munk-Olsen T
Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):105-113. PubMed ID: 29171114
[TBL] [Abstract][Full Text] [Related]
39. Treatment of mental health problems in general practice: a survey of psychotropics prescribed and other treatments provided.
van Rijswijk E; Borghuis M; van de Lisdonk E; Zitman F; van Weel C
Int J Clin Pharmacol Ther; 2007 Jan; 45(1):23-9. PubMed ID: 17256447
[TBL] [Abstract][Full Text] [Related]
40. Ubiquitous Pharmacogenomics (U-PGx): The Time for Implementation is Now. An Horizon2020 Program to Drive Pharmacogenomics into Clinical Practice.
Cecchin E; Roncato R; Guchelaar HJ; Toffoli G;
Curr Pharm Biotechnol; 2017; 18(3):204-209. PubMed ID: 28044932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
